SOA Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3
Closed 853
2022
Q2
$0 Sell
3
-49
-94% -$6.68K ﹤0.01% 851
2022
Q1
$7K Hold
52
﹤0.01% 637
2021
Q4
$8K Hold
52
﹤0.01% 598
2021
Q3
$7K Buy
52
+28
+117% +$4.1K ﹤0.01% 637
2021
Q2
$3K Buy
24
+9
+60% +$1.18K ﹤0.01% 719
2021
Q1
$1K Sell
15
-114
-88% -$14K ﹤0.01% 759
2020
Q4
$15K Buy
+129
New +$15.7K ﹤0.01% 449

Other funds holding DGX

SOA Wealth Advisors's DGX Position: Q3 2022 in Review

SOA Wealth Advisors sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 3 shares.

SOA Wealth Advisors first reported a position in DGX in Q4 2020 and held it in 7 quarters. The position peaked at $15K in Q4 2020. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • SOA Wealth Advisors reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • SOA Wealth Advisors sold 3 Quest Diagnostics shares in Q3 2022.
  • SOA Wealth Advisors first reported a position in Quest Diagnostics in Q4 2020 and held it in 7 quarters.
  • SOA Wealth Advisors's Quest Diagnostics position peaked at $15K in Q4 2020.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on SOA Wealth Advisors's 13F filing for Q3 2022, filed 7 Oct 2022.